Introduction
============

In the 1990s, a comprehensive search was conducted for the genes responsible for Alzheimer\'s disease (AD). A number of dominantly inherited causative mutations were then discovered in the genes encoding β-amyloid precursor protein, presenilin-1 (PS1), and presenilin-2 (PS2) (for reviews, see Hashimoto-Gotoh et al., [@B9]; Lundkvist and Näslund, [@B16]). At the same time, we also sought to identify genes that were involved in AD pathogenesis, and we identified two genes whose transcripts were found more frequently in the cerebral cortex of an AD patient than in a non-AD subject. One of these genes, *kf-1*, was a novel gene that encoded a zinc-binding membrane protein with a RING-H2 finger domain at the C-terminus (Yasojima et al., [@B35]). The *kf-1* gene is conserved in chordates/vertebrates but not in invertebrates such as *Drosophila melanogaster*. Control of the half-life of *kf-1* mRNA may be critical for its biological function, since nucleotide sequences in the 3′-untranslated region, consisting entirely of a stable two-fold-sheet structure, are highly conserved to an unusual extent between humans and mice. This may suggest that the level of KF-1 protein synthesis is regulated strictly in a cell. Northern blot analysis indicates that the *kf-1* gene is expressed most prominently in the brain but more or less throughout the body, except in the liver (Yasojima et al., [@B35]). KF-1 mediates E2-dependent ubiquitination, and thus may play a role in modulating cellular protein levels as an E3 ubiquitin ligase (Lorick et al., [@B15]). Expression of the *kf-1* gene is also elevated in the frontal cortex and hippocampus, but not hypothalamus, of rats after chronic antidepressant treatments such as the administration of a selective serotonin re-uptake inhibitor (SSRI) (Yamada et al., [@B33]), electroconvulsive therapy (Nishioka et al., [@B21]), and repetitive transcranial magnetic stimulation (Kudo et al., [@B14]). Concerning a possible link of the *kf-1* gene expression to other neurodegenerative or psychiatric diseases, we are not aware of any reports appearing in the NIH databases (PubMed and GEO profiles). It is known that depression can be a heralding symptom or prodrome rather than a separate and distinct disorder for AD or dementia (for a review, see Katz, [@B13]). In fact, it has been reported that depression can occur early in the course of AD in *ps1* mutation carriers unaware of their genetic status (Ringman et al., [@B25]). Taken together, these observations suggest that KF-1 plays some role or roles in the regulation of mental disorders such as depression, which include anxiety and mood disorders as the core symptoms.

Anxiety is an instinct that may have been developed in vertebrates to promote adaptive survival by evasion of unnecessary danger. However, excessive anxiety is disadvantageous, because it reduces even behavioral activity that is necessary for adaptation. Thus, there must be underlying mechanisms that have developed as to appropriately regulate anxiety in response to environmental circumstances. For example, the amygdala is thought to be important in the expression of anxiety or fear, and the medial prefrontal cortex plays a key role for fear extinction by regulating amygdala-mediated expression of fear (for a review, see Bishop, [@B2]).

All the antidepressant drugs developed so far are based on the monoamine hypothesis, which assumes that the pathogenesis of depression could be caused by depletion of monoamines like serotonin in the brain, although some recent approaches to the treatment of depression try to move beyond this hypothesis (Norman, [@B22]). Nevertheless, there is no convincing evidence of a primary dysfunction of a specific monoamine system in depression; on the contrary, monoamine depletion does not worsen depression in patients and does not cause depression in healthy volunteers. Testing systems to measure behavioral despair have been developed in rats/mice for screening antidepressant compounds. These model systems include the forced swim test and the tail suspension test, and compounds that elevate monoamine levels in the brain have been found to reduce the immobility time of animals under these conditions of fear and despair (Porsolt et al., [@B23]; Steru et al., [@B28]). It is worth noting that in humans, approximately one-third of patients with depression do not respond to the drugs developed using these tests. To develop drugs to help patients who are unresponsive to currently available antidepressants, it is therefore desirable to have an animal model that mimics the core symptoms of depression, but that does not involve regulation of monoamine levels in the brain.

In the present study, we conducted a comprehensive behavioral test battery on the mice lacking KF-1 and found that *kf-1*^−/−^ mice showed decreased stay time in and number of transitions to the light box in the light/dark transition test, decreased locomotor activity in the elevated plus maze test, and increased immediate freezing in the fear conditioning test, indicating overall increased anxiety-like behavior under stressful situations in these mutant mice. No significant cognitive abnormalities were found in the fear conditioning test and in the forced alternation test using the automatic T-maze. Based on the effect of KF-1 depletion on these anxiety-like behaviors, we propose that *kf-1*^−/−^ mice may suppress selectively anxiety under physiological conditions, and be useful for both investigating the molecular mechanisms of anxiety/depression and screening novel anxiolytic/antidepressant compounds.

Materials and Methods {#s1}
=====================

Targeting vector {#s2}
----------------

Mouse *kf-1* genomic clones were isolated from a 129/Sv λ Fix III genomic DNA library (Stratagene) using mouse *kf-1* cDNA as a hybridization probe. Gene fragments were subcloned into pKF4 and pHSG396 for further analysis and manipulation (Hashimoto-Gotoh, [@B8]; Takeshita et al., [@B31]). The essential portion of the mouse *kf-1* gene was sequenced, including all four exons (Ex) and three introns (In). The DNA segment used to construct the targeting vector was ∼14.7 kb long and was downstream of the *Ase*I site at position 15,600 in In 3. The position numbers for restriction sites are based on the GenBank database (Accession no. AB012161). Schematic representations of the mouse *kf-1* gene, targeting vector, and recombinant and deletion alleles are shown in Figure [1](#F1){ref-type="fig"}A. To delete the critical coding region, i.e., Ex 4, a conditional knockout (KO) procedure using Cre-lox recombination was employed (Sakai and Miyazaki, [@B26]). The resulting targeting DNA was cloned into pHSG396, yielding pHSG396mkf-1Ex4.

![**Schematic presentation of the mouse *kf-1* gene structure, targeting vector, and floxed and knockout alleles**. ***(A)*** For construction of the targeting vector, the diphtheria toxin A (DT-A) and neomycin resistance (neo) genes were inserted in reverse orientation at *Ase*I and *Stu*I sites at positions 15,600 and 17,515, respectively, and loxP cassettes were inserted using *Stu*I and *Bgl*II sites at positions 17,515 in In 3 and 20,081 in Ex 4, respectively. Closed and open boxes indicate the approximate positions of coding and non-coding exons, respectively. P with an arrowhead indicates the 49-bp promoter region identified by the CAT assay (data not shown). *Bsp*HI restriction fragments, 5,861 and 4,759 bp in size, are indicated by open bidirectional-arrows above the *kf-1* (+) and *kf-1* (lox) genomes, respectively. The position corresponding to the 2,428-bp PCR product used to verify homologous recombination between the targeting vector and the *kf-1* gene is shown below the *kf-1* (lox) genome. Restriction sites for *Ase*I, *Bsp*HI, *Bgl*II, and *Stu*I were shown by A, B, Bg, and S, respectively. ***(B)*** Southern blot of *Bsp*HI-digested genomic DNA using the mouse *kf-1* probe. The DNA bands indicated by arrows (5,861 and 4,759 bp) correspond to the *Bsp*HI-fragments shown in ***(A)***. Lanes 1, 2, 3, and 4 are *kf-1*^+/+^, *kf-1*^lox/lox^, *kf-1*^+/−^, and *kf-1*^−/−^, respectively. Note that the intensity of the DNA band in lane 3 is half as intense as in lane 1. ***(C)*** Northern blot analysis of *kf-1* gene expression. Experimental procedures are as described in Sections ['Targeting vector'](#s2){ref-type="sec"} and ['Selection of targeted ES clones and generation of *kf-1*^−/−^ mice'](#s3){ref-type="sec"}. Lanes are as the same in ***(B)***.](fnbeh-02-004-g001){#F1}

Selection of targeted ES clones and generation of *kf-1*^−/−^ mice {#s3}
------------------------------------------------------------------

The selection of targeted ES cells (line R1; Nagy et al., [@B20]) and generation of *kf-1*^−/−^ mice were done essentially as described previously (Matsuki et al., [@B17]). Briefly, ten million ES cells were transfected by electroporation with 25 μg of *Not*I-linearized pHSG396mkf-1Ex4 DNA. After selection with 150 μg/ml of neomycin, 432 clones were analyzed, among which five clones were positive, giving a 2,428-bp PCR product using the forward primer: 5′-CCCTGTCTACCGTTTCTACCCCT-3′ and the reverse primer: 5′-GAATGGGCTGACGCTTCCTCGTG-3′ (Figure [1](#F1){ref-type="fig"}A). One of the clones was expanded and microinjected into BDF1 blastocysts. Male chimeras derived from the clone were mated with C57BL/6N females. Germ-line transmission of the targeted recombination was verified by Southern blot analysis of tail DNA against ^32^P-labeled mouse *kf-1* DNA of the Ex 4 coding region. The resulting *kf-1*^+/lox^ male mice were mated with CAG (Cytomegalovirus immediate early enhancer + chicken β-Actin hybrid promoter + rabbit β-Globin polyA signal containing region) promoter-driven Cre gene containing transgenic female mice (Sakai and Miyazaki, [@B26]). F1 heterozygotes, *kf-1*^+/−^, were then crossed to C57BL/6N, and the resulting F2 heterozygotes were backcrossed to C57BL/6N. This was repeated for eight generations, and then male and female F9 heterozygotes were intercrossed to generate a homozygous *kf-1*^−/−^ line. The lack of *kf-1* gene was verified by Southern hybridization of *Bsp*HI-digested tail DNA using the same probe as above (Figure [1](#F1){ref-type="fig"}B). The absence of *kf-1* mRNA was confirmed by Northern blot analysis using 10 μg of total RNA from the whole-brain against the same probe (Figure [1](#F1){ref-type="fig"}C). The *kf-1*^−/−^ mouse, called the Hicky mouse, may be obtained from the Riken BioResource Center, Japan (BRC No. 01916).

Animals and experimental design
-------------------------------

Prior to behavioral studies, *kf-1*^−/−^ males obtained from the crossing between male and female F9 heterozygotes were mated with C57BL/6N females (*kf-1*^+/+^). The resulting heterozygotes were then intercrossed to produce homozygous *kf-1*^+/+^ and *kf-1*^−/−^ littermates. The behavioral tests were performed with male mice of this generation, which were 10 weeks old at the start of the behavioral studies (*n* = 20 for both groups). Mice were reorganized as soon as they were genotyped at the time of weaning, and group-housed with four mice per cage, two *kf-1*^+/+^ and two *kf-1*^−/−^ littermates. Housing conditions included a 12-h light/dark cycle, with lights on at 7:00 a.m. and access to food and water *ad libitum*. Behavioral testing was performed between 9:00 a.m. and 6:00 p.m., excepting for that of T-maze forced alternation task that was performed between 7:00 p.m. and 5:00 a.m. After the tests, all apparatus were cleaned with super hypochlorous water to prevent a bias based on olfactory cues with the apparatus. The order of each testing is as indicated in Table [1](#T1){ref-type="table"}. All animal experiments, including the production and maintenance protocols, were reviewed and approved by the Animal Care and Use Committee of the Kyoto Prefectural University of Medicine. Behavioral studies were performed in accordance with the guidelines for animal experimentation of Graduate School of Medicine, Kyoto University.

###### 

Comprehensive behavioral test battery and phenotypes of *kf-1*^−/−^ mice.

  Tests                                          Phenotypes   Measurements *kf*-*1*^+/+^, *kf*-*1*^−/−^   *p* and *F* values                  Days
  ---------------------------------------------- ------------ ------------------------------------------- ----------------------------------- --------
  General health                                                                                                                              
   Whisker, coat, reflexes                       ≈            n/a                                         n/a                                 1
  Physical examination                                                                                                                        
   Body temperature (°C)                         ≈            36.99 ± 0.17, 37.15 ± 0.10                  *p *= 0.4146, *F*~1,38 ~= 0.681     1
   Body weight (g)                               ≈            26.35 ± 0.43, 26.70 ± 0.57                  *p *= 0.6254, *F*~1,38 ~= 0.242     1
   Wire-hanging time (sec)                       ↑            44.55 ± 4.21, 55.55 ± 2.27                  *p *= 0.0270, *F*~1,38 ~= 5.295     1
   Grip strength (N)                             ≈            0.83 ± 0.03, 0.86 ± 0.04                    *p *= 0.4060, *F*~1,38 ~= 0.706     2
  Light/dark transition                                                                                                                       
   Anxiety                                       ↑            Figure [9](#F9){ref-type="fig"}             Figure [9](#F9){ref-type="fig"}     3
  Open field                                                                                                                                  
   Exploratory locomotion                        ≈            Figure [3](#F3){ref-type="fig"}             Figure [3](#F3){ref-type="fig"}     7,8
  Elevated plus maze                                                                                                                          
   Anxiety                                       ↑            Figure [10](#F10){ref-type="fig"}           Figure [10](#F10){ref-type="fig"}   9
  Hot plate                                                                                                                                   
   Pain sensitivity (sec)                        ≈            9.7 ± 0.67, 10.5 ± 0.64                     *p *= 0.4045, *F*~1,38~ = 0.711     10
  Social interaction                                                                                                                          
   Total duration of contacts (sec)              ≈            85.9 ± 4.95, 85.0 ± 6.22                    *p *= 0.9101, *F*~1,38~ = 0.002     11
   Number of contacts (times)                    ≈            53.2 ± 4.85, 51.3 ± 3.76                    *p *= 0.7604, *F*~1,38~ = 0.096     11
   Total duration of active contact (sec)        ≈            16.0 ± 1.81, 14.9 ± 1.34                    *p *= 0.6153, *F*~1,38~ =~ ~0.261   11
   Mean duration/contacts (sec)                  ≈            1.7 ± 0.15, 1.7 ± 0.13                      *p *= 0.9609, *F*~1,38~ = 0.002     11
   Distance traveled (cm)                        ≈            3275 ± 140, 3323 ± 172                      *p *= 0.8310, *F*~1,38~ = 0.047     11
  Rotarod                                                                                                                                     
   Motor coordination                            ≈            Figure [4](#F4){ref-type="fig"}             Figure [4](#F4){ref-type="fig"}     14, 15
  Prepulse inhibition                                                                                                                         
   Sensorimotor gating                           ↑            Figure [11](#F11){ref-type="fig"}           Figure [11](#F11){ref-type="fig"}   16
  Porsol forced swim                                                                                                                          
   Immobility time (behavioral despair)          ≈            Figure [5](#F5){ref-type="fig"}             Figure [5](#F5){ref-type="fig"}     17, 18
  T-maze forced alternation task                                                                                                              
   Spatial working memory (cognitive function)   ≈            Figure [7](#F7){ref-type="fig"}             Figure [7](#F7){ref-type="fig"}     41--71
  Contextual and cued fear conditioning                                                                                                       
   Contextual memory (cognitive function)        ≈            Figure [8](#F8){ref-type="fig"}             Figure [8](#F8){ref-type="fig"}     77--78
  Tail suspension                                                                                                                             
   Immobility time (behavioral despair)          ≈            Figure [6](#F6){ref-type="fig"}             Figure [6](#F6){ref-type="fig"}     79

≈, No significant differences between kf-1^+/+^ and kf-1^−/−^; ↑, Increased in kf-1^−/−^ compared to kf-1^+/+^. The testing order was from the 1st to 79th day as indicated in the right column.

General health and neurological screen
--------------------------------------

To compare the physical characteristics of *kf-1*^−/−^ mice and their *kf-1*^+/+^ littermates, we first conducted the neurological screening as previously described (Miyakawa et al., [@B19]). The righting, whiskers touch, and ear twitch reflexes were evaluated, and a number of physical features including body weight and temperature, and the presence of whiskers or bald hair patches were recorded.

Neuromuscular examination
-------------------------

The neuromuscular strength was examined by the grip strength and wire-hanging tests. The grip strength meter (O\'Hara & Co.) was used to assess forelimb grip strength. Mice were lifted and held by their tail so that their forepaws could grasp a wire grid. Mice were then gently pulled backward by the tail with their posture parallel to the surface of the table until they released the grid. The peak force applied by mouse forelimbs was recorded in newtons (N). Each mouse was tested three times and the greatest value measured was used for statistical analysis. In the wire-hanging test, mice were placed on a wire mesh, which was then inverted and waved gently, so that the subject gripped the wire. Latency to fall was recorded, with a 60 s cut-off time.

Light/dark transition test {#s4}
--------------------------

The apparatus used for light/dark transition test consisted of a cage (21 cm × 42 cm × 25 cm) divided into two sections of equal size by a partition with door (O\'Hara & Co., Tokyo). One chamber was brightly illuminated (390 lx), whereas the other chamber was dark (2 lx). Mice were placed into the dark side, and allowed to move freely between the two chambers with door open for 10 min. The total number of transitions, time spent in each compartment, first latency to light side, and distance traveled were recorded automatically. On-line material describing this method is available visually (Takao and Miyakawa, [@B29]).

Open field test {#s5}
---------------

Locomotor activity was measured using the open field test. Each subject was placed in the center of open field apparatus (40 cm × 40 cm × 30 cm; Accuscan Instruments, Columbus, OH, USA). Total distance traveled (centimeters), vertical activity (rearing measured by counting the number of photobeam interruptions), time spent in the center, the beam-break counts for stereotypic behaviors, and the number of fecal boli were recorded. Data were collected for 120 min. Photo beams were positioned 1 cm inside apart from walls at the edge of the open field. If any of these beams was not interrupted, mice were considered to be in the center area.

Elevated plus maze test {#s6}
-----------------------

The elevated plus-maze consisted of two open arms (25 cm × 5 cm) and two enclosed arms of the same size, with 15 cm high transparent walls. The arms and central square were made of white plastic plates, and were elevated to a height of 55 cm above the floor. In order to minimize the likelihood of animals falling from the apparatus, 3-mm high plexiglas ledges were provided for the open arms. Arms of the same type were arranged at opposite sides to each other. Each mouse was placed in the central square of the maze (5 cm × 5 cm), facing one of the closed arms. Mouse behavior was recorded during a 10 min test period. The number of entries into, and the time spent on open and enclosed arms were recorded. For data analysis, we employed the following four measures: the percentage of entries onto open arms, the stay time on open arms (seconds), the number of total entries, and total distance traveled (centimeters). Data acquisition and analysis were performed automatically, using Image EP software.

Hot plate test
--------------

The hot plate test was used to evaluate the nociception or the sensitivity to a painful stimulus. Mice were placed on a hot plate at 55.0 ± 0.3°C (Columbus Instruments, Columbus, OH, USA), and latency to the first hind-paw response was recorded. The hind-paw response was either a foot shake or a paw lick.

Social interaction test in a novel environment
----------------------------------------------

Two mice of identical genotypes, which were previously housed in different cages, were placed into a box together (40 cm × 40 cm × 30 cm) and allowed to explore freely for 10 min. Social behavior was monitored by a CCD camera, which was connected to a Macintosh computer. Analysis was performed automatically using Image SI software. Number of contacts, duration of contacts, and total distance traveled were measured.

Rotarod test {#s7}
------------

Motor coordination and balance were tested with the rotarod test. We performed the rotarod test using an accelerating rotarod (UGO Basile Accelerating Rotarod) by placing a mouse on a rotating drum (3 cm diameter) and measuring the time during which each animal was able to maintain its balance on the rod as latency time to fall (seconds). Speed of the rotarod was accelerated from 4 to 40 rpm over a 5-min period.

Startle response/prepulse inhibition test {#s8}
-----------------------------------------

A startle reflex measurement system was used (O\'Hara & Co., Tokyo). A test session began by placing a mouse in a plexiglas cylinder where it was left undisturbed for 10 min. The duration of white noise that was used as the startle stimulus was 40 ms for all trial types. The startle response was recorded for 140 ms (measuring the response every 1 ms) starting with the onset of the prepulse stimulus. The background noise level in each chamber was 70 dB. The peak startle amplitude recorded during the 140 ms sampling window was used as the dependent variable. A test session consisted of six trial types \[i.e., two types for 'startle-stimulus-only' trials, and four types for prepulse inhibition (PPI) trials\]. The intensity of startle stimulus was 110 or 120 dB. The prepulse sound was presented 100 ms before the startle stimulus, and its intensity was 74 or 78 dB. Four combinations of prepulse and startle stimuli were employed (74--110, 78--110, 74--120, and 78--120 dB). Six blocks of the six trial types were presented in pseudo-random order such that each trial type was presented once within a block. The average inter-trial interval was 15 s (range: 10--20 s).

Porsolt forced swim test {#s9}
------------------------

The Porsolt forced swim test was done essentially as described previously (Miyakawa et al., [@B19]). The apparatus consisted of four plexiglas cylinders (20 cm height × 10 cm diameter). The cylinders were filled with water at 23°C, up to a height of 7.5 cm. Mice were placed into the cylinders, and their behavior was recorded over a 10-min test period (days 1 and 2). Data acquisition and analysis were performed automatically, using Image PS software (see Section ['Image analysis'](#s13){ref-type="sec"}).

T-maze forced alternation task test {#s10}
-----------------------------------

The forced alternation task test was conducted using an automatic T-maze (Figure [2](#F2){ref-type="fig"}). It was constructed of white plastics runways with walls 25-cm high. The maze was partitioned off into six areas by sliding doors that can be opened downward. The stem of T was composed of area S2 (13 cm × 24 cm) and the arms of T were composed of area A1 and A2 (11.5 cm × 20.5 cm). Area P1 and P2 were the connecting passage way from the arm (area A1 or A2) to the start compartment (area S1). The end of each arm was equipped with a pellet dispenser that could provide food reward. The pellet sensors were able to record automatically pellet intake by the mice. One week before the pre-training, mice were deprived of food until their body weight was reduced to 80--85% of the initial level. Mice were kept on a maintenance diet throughout the course of all the T-maze experiments. Before the first trial, mice were subjected to three 10-min adaptation sessions, during which they were allowed to freely explore the T-maze with all doors open and both arms baited with food. On the day after the adaptation session, mice were subjected to a forced alternation protocol for 16 days (one session consisting of 10 trials per day; cutoff time, 50 min). Mice were given 10 pairs of training trials per day. On the first (sample) trial of each pair, the mouse was forced to choose one of the arms of the T (area A1 or A2), and received the reward at the end of the arm. Choosing the incorrect arm resulted in no reward and confinement to the arm for 10 s. After the mouse consumed the pellet or the mouse stayed \>10 s without consuming the pellet, the door that separated the arm (area A1 or A2) and connecting passage way (area P1 or P2) would be opened and the mouse could return to the starting compartment (area S1), via connecting passage way. The mouse was then given 3 s delay there and a free choice between both T arms and rewarded for choosing the other arm that was not chosen on the first trial of the pair. The location of the sample arm (left or right) was varied pseudo-randomly across trials using Gellermann schedule so that mice received equal numbers of left and right presentations. A variety of fixed extra-maze cues surrounded the apparatus. On the 17th to 20th day, delay (10, 30, or 60 s) was applied after the sample trial.

![**Apparatus of T-maze forced alternation task test**.](fnbeh-02-004-g002){#F2}

Contextual and cued fear conditioning {#s11}
-------------------------------------

Each mouse was placed in a test chamber (26 cm × 34 cm × 29 cm) inside a sound-attenuated chamber (O\'Hara & Co., Tokyo) and allowed to explore freely for 2 min. A 60 dB white noise, which served as the conditioned stimulus (CS), was presented for 30 s, followed by a mild (2 s, 0.5 mA) foot shock, which served as the unconditioned stimulus (US). Two more CS--US pairings were presented with 2 min inter-stimulus interval. To examine shock sensitivity, we measured distance traveled when the foot shock were delivered sensitivity (from 2 s before the shock to 2 s after the shock, total 6 s). Context testing was conducted 1 day, 1 week, and 1 month after conditioning in the same chamber. Cued testing with altered context was conducted 1 day after conditioning using a triangular box (35 cm × 35 cm × 40 cm) made of white opaque plexiglas, which was located in a different room. Data acquisition, control of stimuli (i.e., tones and shocks), and data analysis were performed automatically, using Image FZ software. Images were captured at one frame per second. For each pair of successive frames, the amount of area (pixels) by which the mouse moved was measured. When this area was below a certain threshold (i.e., 20 pixels), the behavior was judged as 'freezing'. When the amount of area equaled or exceeded the threshold, the behavior was considered as 'non-freezing'. The optimal threshold (amount of pixels) to judge freezing was determined by adjusting it to the amount of freezing measured by human observation. 'Freezing' that lasted less than the defined time threshold (i.e., 2 s) was not included in the analysis.

Tail suspension test {#s12}
--------------------

The tail suspension test was performed for a 10-min test session according to the procedures described by Steru et al. ([@B28]). Mice were suspended 30 cm above the floor in a visually isolated area by adhesive tape placed ∼1 cm from the tip of the tail, and their behavior was recorded over a 10-min test period. Data acquisition and analysis were performed automatically, using Image TS software (see Section ['Image analysis'](#s13){ref-type="sec"}).

Image analysis {#s13}
--------------

The applications used for the behavioral studies (Image LD, Image EP, Image TM, Image FZ, Image SI, Image TS, and ImageHA) were based on the public domain NIH Image program (developed at the U.S. National Institutes of Health and available on the Internet at <http://rsb.info.nih.gov/nih-image/>) and ImageJ program (<http://rsb.info.nih.gov/ij/>), which were modified for each test by Miyakawa (available through O\'Hara & Co., Tokyo, Japan).

Statistical analysis
--------------------

Statistical analysis was conducted using Stat View (SAS institute). Data were analyzed by two-way ANOVA, or two-way repeated measures ANOVA, unless noted otherwise. Values in tables and graphs were expressed as mean ± SEM.

Results
=======

Structure of the mouse *kf-1* gene and generation of *kf-1*^−/−^ mice
---------------------------------------------------------------------

Initially, we analyzed the human *kf-1* gene for polymorphisms and found a G/A transition at the −13 position before the initiation codon in one of 10 subjects. Subsequently, we analyzed the mouse *kf-1* gene using four independent mouse *kf-1* genomic clones covering an ∼30.3-kb genomic region (see [Materials and Methods](#s1){ref-type="sec"}). The mouse *kf-1* gene lies within an ∼18 kb segment containing four exons. Ex 4, which codes for the 522 C-terminal amino acids of the 683 amino acid KF-1 protein, was chosen as a target for deletion (Figure [1](#F1){ref-type="fig"}A). Ex 4 includes the coding sequences for the transmembrane regions, the ubiquitination site, and the zinc-binding RING-H2 finger domain. F1 heterozygotes, *kf-1*^+/−^, were obtained as described in Materials and Methods. After repeated backcrossing to C57BL/6N, the F9 heterozygotes *kf-1*^+/−^ mice were intercrossed and *kf-1*^+/+^, *kf-1*^+/−^, and *kf-1*^−/−^ mice were produced with the predicted Mendelian ratio, implying that there was no embryonic lethal effect due to the lack of KF-1 in mice. KF-1 was not detectable even in *kf-1*^+/+^ mice using immunohistochemistry or Western blotting due to the low level of KF-1 protein synthesis and also due to KF-1 ubiquitination, although the anti-mKF-1 antibodies we used could detect mouse KF-1 that was exogenously expressed in COS cells. Similar to PS1 and PS2, immunostaining showed that exogenous mouse KF-1 protein was localized to the endoplasmic reticulum membranes and to Golgi bodies (data not shown). For the success of immunohistochemistry against native KF-1 protein, one might need monoclonal antibodies with higher and/or more specific affinity.

Effect of the *kf-1*^−/−^ genotype on somatic parameters and general behavior
-----------------------------------------------------------------------------

KO mice lacking the *kf-1* gene appeared normal and healthy; there were no evident abnormalities in the physical aspects of *kf-1* KO mice, including reproductive capability. We then measured body temperature and weight, as well as grip strength and wire-hanging time. There were no significant differences in these measurements between *kf-1*^+/+^ and *kf-1*^−/−^ littermate mice, excepting for wire-hanging time, namely the *kf-1*^−/−^ mice exhibited significantly longer wire-hanging time than their *kf-1*^+/+^ littermates (Table [1](#T1){ref-type="table"}). Because there were no significant differences in grip strength and body weight between *kf-1*^+/+^ and *kf-1*^−/−^ mice, differences in wire-hanging time did not seem to be rooted in physical differences; instead, this disparity could be a result of psychological differences. In addition, no significant differences were observed in locomotion (Figures [3](#F3){ref-type="fig"}A--D), nociception (Table [1](#T1){ref-type="table"}), social behavior (Table [1](#T1){ref-type="table"}), motor coordination (Figure [4](#F4){ref-type="fig"}), behavioral despair (Figures [5](#F5){ref-type="fig"}A,B and [6](#F6){ref-type="fig"}), or in spatial working memory (Figure [7](#F7){ref-type="fig"}A). Concerning cognitive functions, no significant differences were found in the T-maze forced alternation task test (Figures [7](#F7){ref-type="fig"}A,B) and in context testing or in cued testing with an altered context between *kf-1*^+/+^ and *kf-1*^−/−^, although immediate freezing was significantly enhanced in the *kf-1*^−/−^ mice (Figures [8](#F8){ref-type="fig"}A--C).

![**No significant differences between *kf-1*^+/+^ and *kf-1*^−/−^ mice in open field test**. The *kf-1*^+/+^ and *kf-1*^−/−^ mice were subjected to the open-field test. ***(A)*** Total locomotion distance (*p* = 0.2879, *F*~1,38~ = 1.162). ***(B)*** Count of vertical activity (*p* = 0.7164, *F*~1,38~ = 0.134). ***(C)*** Time spent in the center of the compartment (*p* = 0.3930, *F*~1,38~ = 0.747). ***(D)*** Count of stereotypic behavior (*p* = 0.4435, *F*~1,38~ = 0.600) (see Section ['Open field test'](#s5){ref-type="sec"}). WT and KO stand for *kf-1*^+/+^ and *kf-1*^−/−^ mice, respectively.](fnbeh-02-004-g003){#F3}

![**Normal motor coordination/learning of *kf-1*^+/+^ and *kf-1*^−/−^ mice in the rotarod test**. The *kf-1*^+/+^ and *kf-1*^−/−^ mice were tested on an accelerating rotarod and no significant differences were found between the two genotypes (*p* = 0.5108, *F*~1,38~ = 0.441) (see Section ['Rotarod test'](#s7){ref-type="sec"}). WT and KO stand for *kf-1*^+/+^ and *kf-1*^−/−^ mice, respectively.](fnbeh-02-004-g004){#F4}

![**No significant differences in despair-like behavior between *kf-1*^+/+^ and *kf-1*^−/−^ mice in Porsolt forced swim test**. ***(A)*** Immobility time (%) in each block for day 1 (*p* = 0.3525, *F*~1,38~ = 0.886) and day 2 (*p* = 0.1145, *F*~1,38~ = 2.610). ***(B)*** Total distance (centimeters) traveled in each block for day 1 (*p* = 0.1304, *F*~1,38~ = 2.390) and day 2 (*p* = 0.0435, *F*~1,38~ = 4.362). No significant differences were found between *kf-1*^+/+^ and *kf-1*^−/−^ mice, although significant reduction of distance traveled was barely observed in *kf-1*^−/−^ mice compared to *kf-1*^+/+^ littermates in day 2 (see Section ['Porsolt forced swim test'](#s9){ref-type="sec"}). WT and KO stand for *kf-1*^+/+^ and *kf-1*^−/−^ mice, respectively.](fnbeh-02-004-g005){#F5}

![**Immobility in the tail suspension assay**. Immobility time is presented as % time in each block. There was no significant differences between *kf-1*^+/+^ and *kf-1*^−/−^ in immobility in the tail suspension test (*p* = 0.0855, *F*~1,38~ = 3.118) (see Section ['Tail Suspension Test'](#s12){ref-type="sec"}). WT and KO stand for *kf-1*^+/+^ and *kf-1*^−/−^ mice, respectively.](fnbeh-02-004-g006){#F6}

![**Spatial working memory in T-maze forced alternation task test**. ***(A)*** No significant differences were observed in spatial working memory between *kf-1*^+/+^ and *kf-1*^−/−^ mice as presented by % correct responses (*p* = 0.6146, *F*~1,36~ = 0.258). ***(B)*** On the 17th to 20th trials, the delay was applied after sample trial for 3 s (*p* = 0.3829, *F*~1,36~ = 0.779), 10 s (*p* = 0.6371, *F*~1,36~ = 0.226), 30 s (*p* = 0.6267, *F*~1,36~ = 0.241), or 60 s (*p* = 0.4110, *F*~1,36~ = 0.691). Data are given as mean (±SEM; see Section ['T-maze forced alternation task test'](#s10){ref-type="sec"}). WT and KO stand for *kf-1*^+/+^ and *kf-1*^−/−^ mice, respectively.](fnbeh-02-004-g007){#F7}

![**Levels of freezing in *kf-1*^−/−^ mice during conditioning, cued testing with altered context, and context testing**. ***(A)*** Immediate freezing during conditioning phase (*p* = 0.0211, *F*~1,38~ = 5.788). ***(B)*** Contextual testing conducted 1 day after conditioning (*p* = 0.9891, *F*~1,38~ = 0.0002). ***(C)*** Cued test with altered context (*p* = 0.2352, *F*~1,38~ = 1.455) and pre-tone period (*p* = 0.0774, *F*~1,38~ = 3.294) are shown. There were no significant differences observed between *kf-1*^+/+^ and *kf-1*^−/−^ mice in contextual and cued fear conditioning test, although significant difference was observed in the immediate freezing without conditioning (see Section ['Contextual and cued fear conditioning'](#s11){ref-type="sec"}). WT and KO stand for *kf-1*^+/+^ and *kf-1*^−/−^ mice, respectively.](fnbeh-02-004-g008){#F8}

Light/dark transition and elevated plus maze tests: increased anxiety in *kf-1*^−/−^ mice
-----------------------------------------------------------------------------------------

In the light/dark transition test, *kf-1*^−/−^ mice traveled significantly shorter distances than *kf-1*^+/+^ mice in the light but not in the dark (Figure [9](#F9){ref-type="fig"}A; *p* = 0.0005, *F*~1,38~ = 14.482 and *p* = 0.1471, *F*~1,38~ = 2.190, respectively), and their stay time in the light was reduced significantly as well (Figure [9](#F9){ref-type="fig"}B; *p* = 0.0004, *F*~1,38~ = 15.280). The number of transitions between light and dark was also decreased significantly in *kf-1*^−/−^ mice (Figure [9](#F9){ref-type="fig"}C; *p* = 0.0392, *F*~1,38~ = 4.561). As can be seen in Figures [9](#F9){ref-type="fig"}A,B, the distance traveled and stay time of *kf-1*^−/−^ mice were reduced in parallel against those of *kf-1*^+/+^ mice in the light, implying that mice had equivalent moving capability per second between the two genotypes. These results suggest an elevated level of anxiety, but not a reduced level of physical capability, specific to light conditions in *kf-1*^−/−^ mice, although they did not show an increased photophobic response as observed in the latency time for first entering the light compartment from the dark (Figure [9](#F9){ref-type="fig"}D; *p* = 0.8986, *F*~1,38~ = 0.016).

![**Increased anxiety-like behavior in *kf-1*^−/−^ mice in the light/dark transition test compared to *kf-1*^+/+^ littermates**. Mice were placed individually in the dark compartment at the start of the test. Data are given as mean (±SEM). ***(A)*** Distance traveled (centimeters) in the light and dark sides. ***(B)*** Time (seconds) the mice stayed in the light side. ***(C)*** Number of transitions between the light and dark sides. ***(D)*** Latency time (seconds) before the first entry into the light side. \**p* \< 0.05; \*\*\**p* \< 0.0005 (see Section ['Light/dark transition test'](#s4){ref-type="sec"}). WT and KO stand for *kf-1*^+/+^ and *kf-1*^−/−^ mice, respectively.](fnbeh-02-004-g009){#F9}

The results of elevated plus maze test were similar. The number of entries into the crossing center from open and closed arms, and the total distance traveled, were decreased significantly in *kf-1*^−/−^ mice compared to their *kf-1*^+/+^ littermates (Figures [10](#F10){ref-type="fig"}A,B; *p* = 0.0005, *F*~1,38~ = 14.758 and *p* = 0.0016, *F*~1,38~ = 11.555, respectively), suggesting increased anxiety in *kf-1*^−/−^ mice under stressful situation on heights. However, no significant differences were observed in % number of entries into and % stay time on the open arms between the two genotypes as observed in Figures [10](#F10){ref-type="fig"}C,D (*p* = 0.6548, *F*~1,38~ = 0.203 and *p* = 0.2490, *F*~1,38~ = 1.371, respectively). No significant differences in these parameters may be due to a floor effect. Some mice did not visit in fact the open arms at all in both the genotypes, 3 and 5 mice in *kf-1*^+/+^ and *kf-1*^−/−^, respectively. Alternatively, the discrepancy between the two tests (Figures [9](#F9){ref-type="fig"}A--C vs. Figures [10](#F10){ref-type="fig"}C,D) may reflect the different aspect of anxiety-like behaviors (see also [Discussion](#s14){ref-type="sec"}).

![**Performance of *kf-1*^−/−^ mice in the elevated plus maze test**. At the start of the test, mice were placed individually in the crossing center from open and closed arms. Data are given as mean (±SEM). ***(A)*** Number of entries into the center crossing between open and closed arms. ***(B)*** Total distance (centimeters) traveled. ***(C)*** % Number of entries into open arms. ***(D)*** % Time spent on open arms. Note that the closed arms were enclosed at both sides by transparent walls, and therefore mice could recognize visibly their position on heights even on the closed arms. \*\**p* \< 0.005; \*\*\**p* \< 0.0005 (see Section ['Elevated plus maze test'](#s6){ref-type="sec"}). WT and KO stand for *kf-1*^+/+^ and *kf-1*^−/−^ mice, respectively.](fnbeh-02-004-g010){#F10}

Prepulse inhibition test: increased sensorimotor gating
-------------------------------------------------------

The PPI test is used widely to measure deficits in information-processing abilities or sensorimotor gating in schizophrenic patients (Geyer and Ellenbroek, [@B6]), and can be employed in both human and animal experiments (Arguello and Gogos, [@B1]). PPI is defined as the degree (%) to which the acoustic startle response is reduced when the startle-eliciting stimulus is preceded by a brief, low-intensity, non-eliciting stimulus, and can be used in both human and animal experiments. The *kf-1*^−/−^ mice had lower startle amplitudes than their *kf-1*^+/+^ littermates at either 110 or 120 dB in 'startle-stimulus-only' trials for all stimulus amplitudes (Figure [11](#F11){ref-type="fig"}A; *p* = 0.0043, *F*~1,38~ = 9.226). Interestingly, the percent PPI, an index of sensorimotor gating, was significantly greater in *kf-1*^−/−^ than in *kf-1*^+/+^ (Figure [11](#F11){ref-type="fig"}B; overall ANOVA including all four conditions, *p* = 0.0023, *F*~1,38~ = 10.676). Although a significant difference between genotypes was not observed when the startle stimulus intensity was 120 dB (*p* = 0.0935, *F*~1,38~ = 2.960), the difference between genotypes was significant at the startle stimulus intensity of 110 dB (*p* = 0.0013, *F*~1,38~ = 11.973). The reduced PPI values at 120 dB than those at 110 dB may be a ceiling effect caused by the strong intensity of the startle stimulus.

![**Reduced startle amplitude and increased prepulse inhibition in *kf-1*^−/−^ mice**. ***(A)*** Startle amplitude was significantly reduced in 'startle-stimulus-only' trials (*p* = 0.0043). ***(B)*** % Prepulse inhibition was significantly increased in *kf-1*^−/−^ compared to that in *kf-1*^+/+^ mice (overall ANOVA including all four conditions, *p* = 0.0023). Data are given as mean (±SEM; see Section ['Startle response/prepulse inhibition test'](#s8){ref-type="sec"}). WT and KO stand for *kf-1*^+/+^ and *kf-1*^−/−^ mice, respectively.](fnbeh-02-004-g011){#F11}

Discussion {#s14}
==========

The mouse *kf-1* gene is expressed throughout the body, except in the liver; the highest expression is in the brain (Yasojima et al., [@B35]). However, the lack of *kf-1* gene did not lead to any obvious abnormalities in appearance or in behaviors such as exploratory locomotion, nociception, social behavior, motor coordination, behavioral despair, spatial working memory, and context memory (Table [1](#T1){ref-type="table"}; Figures [3--8](#F3 F4 F5 F6 F7 F8){ref-type="fig"}). The exception to this is that *kf-1*^−/−^ mice displayed a pronounced increase in anxiety-like behavior in the light/dark transition test (Figures [9](#F9){ref-type="fig"}A--C). In addition, 'timidity-like' responses were observed, under stressful situations, as prolonged wire-hanging time (Table [1](#T1){ref-type="table"}), enhanced immediate freezing with an aversive foot shock (Figure [8](#F8){ref-type="fig"}A), and decreased locomotor activity on heights (Figures [10](#F10){ref-type="fig"}A,B) in *kf-1*^−/−^ mice. Since no significant differences were observed between *kf-1*^+/+^ and *kf-1*^−/−^ mice in body weight and grip strength (Table [1](#T1){ref-type="table"}), and in exploratory locomotion using the open field test (Figure [3](#F3){ref-type="fig"}A), these behaviors should be rooted in psychological, but not physical, alteration in *kf-1*^−/−^ mice. These responses are consistent with the increased anxiety-like behavior observed in the light/dark transition test. However, there was no significant difference regarding the stay time index on open arms between *kf-1*^+/+^ and *kf-1*^−/−^ mice in the elevated plus maze test (Figures [10](#F10){ref-type="fig"}C,D). How can we explain this apparent discrepancy (Figures [9](#F9){ref-type="fig"}A--C and Figures [10](#F10){ref-type="fig"}A,B vs. Figures [10](#F10){ref-type="fig"}C,D)? In the laboratory of T.M., a comprehensive behavioral test battery has been conducted with identical protocols on \>70 different KO and transgenic mice in the past 5 years (Takao et al., [@B30]). Although there were several strains of mutant mice that showed increased anxiety-like behavior, *kf-1*^−/−^ mice were the second greatest mice among them in terms of the size of genotype effect on 'stay time in light' index of the light/dark transition test {δ = −1.058, where δ = \[(average of mutant stay time in light) − (average of wild type stay time in light)\]/(total SD)} (Takao and Miyakawa, data not shown). Considering the large genotype effect observed in the light/dark transition test (Figures [9](#F9){ref-type="fig"}A--C), we believe that this apparent discrepancy is due to a floor effect in the elevated plus maze test or to the difference of the kind of anxiety-like behaviors that were assessed by these two tests. By a factor analysis using our large set of data using \>5,000 mice, we are aware that these two tests assesses different aspects of anxiety-like behavior, although there are significant correlations between indices in these tests (Yamasaki et al., [@B34]). There are also published data indicating that different anxiety tests measure different aspects of anxiety-like behaviors (Holmes et al., [@B11]; Ramos and Mormède, [@B24]; Turri et al., [@B32]). One but not another assay could provide evidence of altered anxiety-like behavior. To distinguish different anxiety-related behavioral dimensions, *kf-1*^−/−^ mice would have to be tested further by another anxiety-related behavioral tests including elevated plus maze with opaque walls, square maze, mirror chamber, and so on.

Considering the fact that the level of *kf-1* gene expression is augmented in the frontal cortex and hippocampus, but not in the hypothalamus, after chronic antidepressant treatments (Kudo et al., [@B14]; Nishioka et al., [@B21]; Yamada et al., [@B33]), these results suggest that *kf-1* gene may play a role(s) in the emotional regulation such as the suppression of anxiety or fear under stressful conditions. In this context, it is worth to note that roles of prefrontal cortex and hippocampus in modulating amygdala activity have been reported to be responsible for adaptive emotional regulation of context-specific retrieval of anxiety or fear extinction (Corcoran et al., [@B5]; Sotres-Bayon et al., [@B27]). Therefore, our observations suggesting a possible 'antianxiety'-like effect of KF-1 seem to be consistent with all these reports. Since KF-1 is an E3 ubiquitin ligase to modulate cellular protein level (Lorick et al., [@B15]), it appears to be crucial to identify what is (are) the target protein(s) degraded depending on KF-1 ubiquitination in the future studies. Cellular concentration of this putative target protein(s) may have played an important role during the vertebral evolution to determine the anxiety level to defy or evade potential dangers in various environmental circumstances.

The *kf-1* gene expression is up-regulated in the frontal cortex of rats treated by chronic SSRI administration (Yamada et al., [@B33]). It may be possible that the effect of KF-1 depletion on anxiety-like behavior could be associated with the dysregulation of serotonergic system in these mutant mice. Increased anxiety-like behavior has been reported in mice lacking serotonin-related genes. For example, mice (C57BL/6J) lacking the serotonin receptor gene (*5-HT~1A~*) displayed increased 'anxiety' levels in the open-field, elevated zero maze, and novel-object tests (Heisler et al., [@B10]). Similarly, mice lacking the gene (*5-HTT*) for serotonin transporter were shown to have increased 'anxiety'-like behavior in the light/dark transition, elevated plus maze, and open-field tests on the C57BL/6J background (Holmes et al., [@B12]). It has been pointed out that the absence of the *5-HT~1A~* gene during the postnatal developmental period, but not in adult mice, affects anxiety-like behavior (Gross et al., [@B7]). It would be necessary, therefore, to determine in the future studies whether the behavioral abnormality of *kf-1*^−/−^ mice is caused by a developmental impairment by KF-1 depletion or its absence at adulthood.

Concerning the possible association of the *kf-1* gene with AD, no significant effects of genotype were observed on memory or cognitive function in the present studies (Figures [7](#F7){ref-type="fig"} and [8](#F8){ref-type="fig"}). Interestingly, *kf-1*^−/−^ mice exhibited significantly increased PPI values (Figure [11](#F11){ref-type="fig"}), which are usually reduced in human schizophrenic patients (Geyer and Ellenbroek, [@B6]). PPI deficit has been reported also in mouse models of schizophrenia (Chen et al., [@B3]; Clapcote et al., [@B4]; Miyakawa et al., [@B18]). Taking these reports into account, agents that can inhibit the expression or function of the *kf-1* gene, if any, could possibly ameliorate sensorimotor-gating deficits that are seen in patients of schizophrenia and other psychiatric disorders. Finally, it will be interesting to see whether or not the G/A transition in front of the initiation codon of the human *kf-1* gene influences the mRNA translation efficiency. In conclusion, the *kf-1*^−/−^ mice and cells derived thereof may be useful for elucidating the molecular mechanism of anxiety/depression, and furthermore, the *kf-1*^−/−^ mice may provide a useful tool for finding novel anxiolytic/antidepressant compounds, which may compensate KF-1 by antagonizing its target protein(s).
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